北美白细胞去除术市场预测至 2028 年 - COVID-19 影响和按产品类型（白细胞去除术设备和白细胞去除术一次性用品）、应用（研究应用和治疗应用）和最终用户（血液成分提供商和血液中心、学术和研究机构）进行的区域分析、制药和生物技术公司以及医院和输血中心）
市场介绍
北美白细胞去除术市场基于三个大国进行分析：美国、加拿大和墨西哥。美国地区在白细胞分离术市场的增长中贡献了主要份额。根据2017年联合国老龄化报告，全球60岁及以上人口有9.62亿，预计到2050年这一数字将达到近21亿。美国65岁及以上的人数预计将到 2060 年，这一数字将增加一倍多，从 2016 年的 4600 万增加到 9800 万以上。世界 65 岁及以上人口的比例预计将增加 15%。伴有白细胞停滞的 AML 中白细胞增多症是一种严重危及生命的疾病，早期死亡率很高，需要立即进行细胞减灭治疗。美国血浆分离术协会目前建议对白细胞计数>10的患者进行治疗性白细胞分离术。 100 G/L 有白细胞停滞迹象。输血医疗服务将在大多数提供这种治疗方式的美国医疗中心进行单采术。严格的规则规定了程序如何执行以及谁可以执行这些程序（即培训和监督水平）。因此，血库适用于外周血干的整个采集过程，因为它基本上是白细胞分离术的一种变体。此外，由于产品的加工和储存通常在血库中进行，整个过程都在一个单位的监督下，这使得质量控制变得更加容易。据美国癌症协会称，2020年新诊断出各类白血病病例60,530例，死亡人数为23,100人。急性髓系白血病在美国最为常见，有 19,940 例病例。此外，研发和新技术进步是推动市场增长的其他因素。
自 COVID-19 爆发以来，北美的病例数量不断增加。墨西哥的病例也在增加。在墨西哥。目前，大多数诊断实验室和研究机构都在从事COVID-19患者的诊断。目前，由于病例数量不断增加，加上监管机构的紧急使用授权不断增加，COVID-19诊断测试行业正在蓬勃发展。此外，随着世界卫生组织宣布 COVID-19 疫情为大流行病，许多知名制药和生物制药公司以及小型初创公司已开始开发针对感染的治疗方法。美国食品和药物管理局发布了血液净化系统的紧急使用授权，用于治疗入住重症监护病房 (ICU) 并确诊或即将发生呼吸衰竭的 18 岁或以上确诊 2019 年冠状病毒病 (COVID-19) 的患者。 FDA 向 Terumo BCT Inc. 和 Marker Therapeutics AG 颁发了紧急使用授权，用于其 Spectra Optia Apheresis 系统和 Depuro D2000 吸附盒设备。
市场概况和动态
北美白细胞分离术市场预计将从2021年的2854万美元增长到2028年的5265万美元；据估计，从 2021 年到 2028 年，该数字将以 9.1% 的复合年增长率增长。由于采用现代化设施导致生活方式的改变，发展中国家血液相关疾病的发病率正在上升。设施的现代化导致人们的身体活动减少，而不像由于各种专业和个人因素而增加的压力水平。发展中国家非常注重医疗保健设施的进步。例如，血友病联合会 (HFI) 是一个非营利组织，它与世界血友病联合会 (WFH) 密切合作，以传播意识并教育人们有关可负担的血友病治疗方法，从而改善诊断和治疗。因此，上述因素为白细胞分离术市场的增长提供了机会。
关键细分市场
就以下方面而言：从产品类型来看，白细胞分离术一次性用品细分市场在 2021 年占据了较大份额。从应用来看，研究应用细分市场在 2021 年占据了最大份额。基于最终用户，血液成分提供商和血液中心细分市场在 2021 年占据最大份额。
主要来源和上市公司
<准备本北美白细胞分离术市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有：旭化成株式会社；费森尤斯公司两合公司；血液公司；泰尔茂公司； STEMCELL 技术公司；赫马护理；玛科制药公司；所有细胞；干快递；和 BioIVT 等。购买报告的理由
- 了解北美白细胞分离术市场格局，并确定最有可能保证强劲回报的细分市场
- 通过了解不断变化的变化，保持竞争优势北美白细胞分离术市场的竞争格局
- 通过确定最有可能销售的细分市场，有效规划北美白细胞分离术市场的并购和合作交易
- 帮助做出明智的业务决策通过对北美白细胞分离术市场各个细分市场表现的敏锐和全面的分析
- 获得北美地区2021-2028年各个细分市场的市场收入预测。 li>
北美白细胞分离术市场细分
北美白细胞去除术市场 –按产品类型
- 白细胞去除一次性用品
- 白细胞去除设备
North美国白细胞分离术市场 –按应用
- 研究应用
- 治疗应用
北美白细胞去除术市场 –按产品类型
- 血液成分提供商和血液中心
- 医院和输血中心
- 制药和生物技术公司
- 学术和研究机构
北美白细胞去除术市场 -按国家/地区
- 美国
- 加拿大
- 墨西哥
北美白细胞去除术市场 –提及的公司
- 旭化成株式会社
- Fresenius SE &
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc. ;
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Leukapheresis Market – By Product Type
1.3.2 North America Leukapheresis Market – By Application
1.3.3 North America Leukapheresis Market – By End User
1.3.4 North America Leukapheresis Market – By Country
2. North America Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Leukapheresis Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. North America Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Number of Voluntary Blood Donors
5.1.2 Raising Incidence of Hematologic Diseases
5.1.3 Up-lifting Elderly Population
5.2 Key Market Restraints
5.2.1 High Price of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Growing Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Progress in Therapeutic Apheresis
5.5 Impact Analysis
6. North America Leukapheresis – Market Analysis
6.1 North America Leukapheresis Market Revenue Forecast and Analysis
7. North America Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. North America Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 North America Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. North America Leukapheresis Market Analysis – by End User
9.1 Overview
9.2 North America Leukapheresis Market Share by End User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. North American Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 North America: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Leukapheresis Market– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 US: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.1.1.3.1 US: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.4 US: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 US: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Canada: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.1.2.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.4 Canada: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.5 Canada: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.3 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 Mexico: Leukapheresis Market, by Product type – 2019–2028 (USD Million)
10.1.1.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.4 Mexico: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 Mexico: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. North America Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment of COVID-19 Pandemic
12. Leukapheresis Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. US Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. North America Leukapheresis Market Segmentation
Figure 2. North America Leukapheresis Market Segmentation, By country
Figure 3. North America Leukapheresis Market Overview
Figure 4. North America Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America Leukapheresis Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America Leukapheresis market impact analysis of driver and restraints
Figure 9. North America Leukapheresis Market – Revenue Forecast and Analysis (2021-2028)
Figure 10. North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. North America Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. North America Leukapheresis Market Share by End User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. North America: Leukapheresis Market, by Key Country – Revenue (2021 USD Million)
Figure 25. North America: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in North American Country Markets
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution